GAS5 and type 2 diabetes mellitus: This agent binds lncRNA GAS5 with high affinity in adipose-derived stem cells, hinders its interaction with UPF1, and prevents lncRNA GAS5 degradation, thereby alleviating type 2 diabetes [40].